Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
Céline Chapelle, Biostatistician at CHU Saint-Étienne, shared on LinkedIn:
“Very happy to share our latest publication in Lancet Haematology.
“Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial”
In this post-hoc analysis of the API-CAT study, including patients with cancer-associated thromosis (CAT) receiving extended anticoagulant with apixaban: – Four clinical predictors were significantly associated with an increased risk of clinically relevant bleeding: anaemia and/or thrombocytopenia, age ≥75, pulmonary embolism as the index event, and male sex.
Three of them were also significant predictors of major bleeding.
Many thanks to all co-authors and collaborators for this excellent teamwork.”
Read the full article here.
Article: Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Authors: Isabelle Mahé, Céline Chapellee, Philippe Girard, Marc Carrier, Luis Jara Palomares, Charles-Marc Samama, Hélène Helfer, Prof Grigoris Gerotziafas, Silvy Laporte, Eric Vicaut, Patrick Mismetti
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 25, 2026, 15:42Francesco Lo Monaco on Heart Disease Starting Quiet While Your Labs Speak First
-
Jan 25, 2026, 15:33Wilfried Dinh: Why Heart Patients Still Have Events Despite ”Optimal” Cardiovascular Therapy
-
Jan 25, 2026, 15:25Muhammad Ibrahim on Efficacy and Safety of Extended DOACs Use in VTE
-
Jan 25, 2026, 15:08Tushar Pandey on Managing Thrombotic Thrombocytopenic Purpura
-
Jan 25, 2026, 14:55Carolina Contreras Cuevas Shares a Nationwide Study on VTE in PAD
-
Jan 25, 2026, 14:40Jeannie Devereaux Links PRP and Physical Therapy
-
Jan 25, 2026, 14:25Heghine Khachatryan on Anticoagulation After AFib Ablation: New Evidence from NEJM
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC